1-4 of 4
David Ingram
Close
Sort by
Journal Articles

Imatinib Mesylate Reduces Plexiform Neurofibromas by Targeting the Hematopoietic Microenvironment.

Feng-Chun Yang, MD, PhD, David Ingram, M.D., Shi Chen, M.D., Ph.D., Kent Robertson, M.D., Ph.D., Xiohong Li, Jin Yuan, Scott Knoll, Whitney Horn, Gary Hutchins, M.D., Ph.D., L. Parada, Ph.D., David Wade Clapp, M.D.
Journal: Blood
Blood (2007) 110 (11): 1915.
https://doi.org/10.1182/blood.V110.11.1915.1915
Published: 2007
Journal Articles

Kinase Suppressor of Ras Plays a Critical Role in Modulating Inflammatory Mast Cell Functions.

Meng Chen, Whitney Horn, Xiaohong Li, Scott Knowles, David Ingram, M.D./Ph.D., Shi Chen, M.D./Ph.D., Feng-Chun Yang, M.D./Ph.D., D. Wade Clapp, M.D.
Journal: Blood
Blood (2007) 110 (11): 2407.
https://doi.org/10.1182/blood.V110.11.2407.2407
Published: 2007
Journal Articles

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100

Clinical Trials & Observations
Rebecca M. Shepherd, Benjamin J. Capoccia, Steven M. Devine, John DiPersio, Kathryn M. Trinkaus, David Ingram, Daniel C. Link
Journal: Blood
Blood (2006) 108 (12): 3662–3667.
https://doi.org/10.1182/blood-2006-06-030577
Published: 2006
Journal Articles

Genetic evidence for convergence of c-Kit– and α 4 integrin–mediated signals on class I A PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells

Bai Lin Tan, Mustafa N. Yazicioglu, David Ingram, Jennifer McCarthy, Jovencio Borneo, David A. Williams, Reuben Kapur
Journal: Blood
Blood (2003) 101 (12): 4725–4732.
https://doi.org/10.1182/blood-2002-08-2521
Published: 2003